ATE282411T1 - Eisenverbindungen - Google Patents

Eisenverbindungen

Info

Publication number: ATE282411T1
Authority: AT; Austria
Prior art keywords: iron; iron joints; joints; hydroxypyrone; bloodstream
Prior art date: 2000-09-19

Application number

AT01967474T

Other languages

English (en)

Inventor

Michael Arthur Stockham

Original Assignee

Vitra Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-19

Filing date

2001-09-10

Publication date

2004-12-15

2000-09-19 Priority claimed from GB0022881A external-priority patent/GB0022881D0/en

2001-03-21 Priority claimed from GB0107031A external-priority patent/GB0107031D0/en

2001-09-10 Application filed by Vitra Pharmaceuticals Ltd filed Critical Vitra Pharmaceuticals Ltd

2004-12-15 Application granted granted Critical

2004-12-15 Publication of ATE282411T1 publication Critical patent/ATE282411T1/de

Links

XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title abstract 4
229910052742 iron Inorganic materials 0.000 title abstract 2
239000000203 mixture Substances 0.000 abstract 2
LIPRKYKMVQPYPG-UHFFFAOYSA-N 3-Hydroxy-2H-pyran-2-one Chemical compound OC1=CC=COC1=O LIPRKYKMVQPYPG-UHFFFAOYSA-N 0.000 abstract 1
206010017964 Gastrointestinal infection Diseases 0.000 abstract 1
208000019836 digestive system infectious disease Diseases 0.000 abstract 1
BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 abstract 1
239000000843 powder Substances 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT01967474T 2000-09-19 2001-09-10 Eisenverbindungen ATE282411T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0022881A GB0022881D0 (en)	2000-09-19	2000-09-19	Iron compositions
GB0107031A GB0107031D0 (en)	2001-03-21	2001-03-21	Iron compositions
PCT/GB2001/004052 WO2002024196A1 (en)	2000-09-19	2001-09-10	Iron compositions

Publications (1)

Publication Number	Publication Date
ATE282411T1 true ATE282411T1 (de)	2004-12-15

Family

ID=26245020

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01967474T ATE282411T1 (de)	2000-09-19	2001-09-10	Eisenverbindungen

Country Status (8)

Country	Link
US (1)	US7135196B2 (de)
EP (1)	EP1318804B1 (de)
AT (1)	ATE282411T1 (de)
AU (1)	AU2001287850A1 (de)
CA (1)	CA2421410C (de)
DE (1)	DE60107272T2 (de)
ES (1)	ES2236300T3 (de)
WO (1)	WO2002024196A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007089578A2 (en) *	2006-01-30	2007-08-09	Globoasia, Llc	Method for selecting phosphate binder and its uses thereof
US20080058408A1 (en)	2006-05-19	2008-03-06	Rogowski Roberta L	Low-dose doxepin for treatment of sleep disorders in elderly patients
US20100179214A1 (en)	2006-05-19	2010-07-15	Somaxon Pharmaceuticals, Inc.	Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
WO2007142810A2 (en)	2006-05-19	2007-12-13	Somaxon Pharmaceuticals, Inc.	Methods of using low-dose doxepin for the improvement of sleep
US20100179215A1 (en)	2006-05-19	2010-07-15	Somaxon Pharmaceuticals, Inc.	Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
WO2007136741A2 (en) *	2006-05-19	2007-11-29	Somaxon Pharmaceuticals, Inc.	N-desmethyl-doxepin and methods of using the same to treat sleep disorders
CA2693992C (en)	2006-07-20	2017-01-31	Somaxon Pharmaceuticals, Inc.	Methods of improving the pharmacokinetics of doxepin
US20080182890A1 (en) *	2006-10-04	2008-07-31	Somaxon Pharmaceuticals, Inc.	Methods of using low-dose doxepin for the improvement of sleep
WO2008052139A2 (en)	2006-10-25	2008-05-02	Somaxon Pharmaceuticals, Inc.	Ultra low dose doxepin and methods of using the same to treat sleep disorders
WO2008070795A2 (en) *	2006-12-06	2008-06-12	Somaxon Pharmaceuticals, Inc.	Combination therapy using low-dose doxepin for the improvement of sleep
CA2721133C (en)	2007-04-13	2018-11-06	Somaxon Pharmaceuticals, Inc.	Low-dose doxepin formulations and methods of making and using the same
GB0808835D0 (en) *	2008-05-15	2008-06-18	Vitra Pharmaceuticals Ltd	Therapeutic compositions
US10179120B2 (en)	2014-01-06	2019-01-15	Iron Therapeutics Holdings Ag	Dosage regimen of ferric trimaltol
GB201418710D0 (en)	2014-10-21	2014-12-03	Iron Therapeutics Holdings Ag	Dosage regimen
GB2553099A (en) *	2016-08-19	2018-02-28	Shield Tx Uk Ltd	Use
MX2020000691A (es) *	2017-07-20	2020-07-29	Nutreco Ip Assets Bv	Composicion de mineral traza.
CN112203639A (zh) *	2018-05-16	2021-01-08	法国诗华大药厂	兽医学组合物和其用于控制非人类哺乳动物的铁缺乏的用途
CN115177625A (zh) *	2022-06-28	2022-10-14	金陵药业股份有限公司	一种羧基麦芽糖铁药用组合物及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3130204A (en)	1962-02-07	1964-04-21	Pfizer & Co C	Preparation of gamma-pyrones
DE1518098A1 (de)	1963-09-19	1969-04-10	Pfizer & Co C	Verfahren zur Herstellung von Pyromekonsaeurederivaten
SE322866B (de)	1966-12-15	1970-04-20	Astra Ab
GB1178874A (en)	1967-08-02	1970-01-21	Mallinckrodt Chemical Works	A Stable Pharmaceutical Composition
US4018907A (en)	1975-08-25	1977-04-19	General Foods Corporation	Coloring food with iron-complexes
US4279936A (en)	1979-09-24	1981-07-21	William Underwood Company	Maltol treated canned meat process
EP0094149B1 (de)	1982-03-24	1986-09-10	National Research Development Corporation	Pharmazeutische Zusammensetzungen, die Eisen-Komplexe von N-substituierten 3-Hydroxypyrid-2-on- oder -4-on-Derivaten enthalten
GR78491B (de)	1982-03-24	1984-09-27	Nat Res Dev
EP0107458B1 (de)	1982-10-22	1987-07-29	National Research Development Corporation	Pharmazeutische Zusammensetzungen
GB8308055D0 (en)	1983-03-24	1983-05-05	Hider R C	Pharmaceutical compositions
GB8308054D0 (en)	1983-03-24	1983-05-05	Hider R C	Pharmaceutical compositions
GB8325496D0 (en)	1983-09-23	1983-10-26	Hider R C	Pharmaceutical compositions
USRE34313E (en)	1983-09-23	1993-07-13	National Research Development Corporation	Pharmaceutical compositions
GB8325494D0 (en)	1983-09-23	1983-10-26	Hider R C	Pharmaceutical compositions
US4912118A (en)	1983-09-23	1990-03-27	National Research Development Corporation	Pharmaceutical compositions
GB8329043D0 (en)	1983-10-31	1983-11-30	Hider R C	Pharmaceutical compositions
GB8410290D0 (en)	1984-04-19	1984-05-31	Callingham B A	Pharmaceutical compositions
US5177068A (en)	1984-04-19	1993-01-05	National Research Development Corporation	Pharmaceutical compositions
GB8410289D0 (en)	1984-04-19	1984-05-31	Callingham B A	Pharmaceutical compositions
GB8606913D0 (en)	1986-03-20	1986-04-23	Hider R C	Treatment of sickle cell disease
IT1204069B (it)	1986-05-30	1989-03-01	Menarini Sas	Utilizzazione della forma farmaceutica per uso orale di sali ferrosi impiegabili in terapia nelle forme di anemia da carenza di ferro
JPH0367565A (ja)	1989-08-07	1991-03-22	Kansai Paint Co Ltd	鉄分強化食品
GB9209078D0 (en)	1992-04-27	1992-06-10	Hider Robert C	Pharmaceutical compositions
GB9217099D0 (en)	1992-08-12	1992-09-23	British Tech Group	Pharmaceutical compositions
EP0833627B1 (de)	1995-06-10	2004-08-18	Vitra Pharmaceuticals Ltd.	Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon
GB9621273D0 (en) *	1996-10-11	1996-11-27	Cortecs Ltd	Therapeutic method

2001
- 2001-09-10 AU AU2001287850A patent/AU2001287850A1/en not_active Abandoned
- 2001-09-10 ES ES01967474T patent/ES2236300T3/es not_active Expired - Lifetime
- 2001-09-10 DE DE60107272T patent/DE60107272T2/de not_active Expired - Lifetime
- 2001-09-10 EP EP01967474A patent/EP1318804B1/de not_active Expired - Lifetime
- 2001-09-10 WO PCT/GB2001/004052 patent/WO2002024196A1/en not_active Ceased
- 2001-09-10 CA CA002421410A patent/CA2421410C/en not_active Expired - Lifetime
- 2001-09-10 US US10/380,751 patent/US7135196B2/en not_active Expired - Lifetime
- 2001-09-10 AT AT01967474T patent/ATE282411T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO2002024196A1 (en)	2002-03-28
CA2421410A1 (en)	2002-03-28
DE60107272T2 (de)	2005-10-27
US7135196B2 (en)	2006-11-14
ES2236300T3 (es)	2005-07-16
EP1318804B1 (de)	2004-11-17
US20040029853A1 (en)	2004-02-12
DE60107272D1 (de)	2004-12-23
EP1318804A1 (de)	2003-06-18
CA2421410C (en)	2009-11-10
AU2001287850A1 (en)	2002-04-02

Legal Events

Date	Code	Title	Description
2005-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE282411T1 (de)	2004-12-15	Eisenverbindungen
TW200518753A (en)	2005-06-16	Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
GB0025173D0 (en)	2000-11-29	Therapeutic agents
EP1426375A3 (de)	2004-12-15	Analgetische Spiroindolderivate
ATE428456T1 (de)	2009-05-15	Antimikrobielle medizinische artikel
DE60144514D1 (de)	2011-06-09	Verwendung von il-18 inhibitoren
TNSN04034A1 (en)	2006-06-01	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
MY130555A (en)	2007-06-29	Super absorbent polymer composition
EA199700032A1 (ru)	1997-12-30	Дезинфицирующий состав "велтолен"
DE69633178D1 (de)	2004-09-23	Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon
DE60115466D1 (de)	2006-01-05	Wirkstoffvorläufer von imidazopyridin-derivaten
DK1294379T3 (da)	2009-06-02	En hidtil ukendt anvendelse af deferipron
TR200402070T4 (tr)	2004-09-21	Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
TR200100896T2 (tr)	2001-09-21	İkameli propanol türevleri, imalat yöntemleri, bileşimleri içeren ilaçlar, kullanımları
DE60121048D1 (de)	2006-08-03	PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
ATE134294T1 (de)	1996-03-15	Zusammensetzung mit psyllium
SE0004101D0 (sv)	2000-11-09	New use
EE200300213A (et)	2003-08-15	SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
MXPA02007903A (es)	2004-09-10	Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
ATE317263T1 (de)	2006-02-15	Diphosphonat derivate von therapeutisch wirksamen stoffen
TR199802270A2 (xx)	1999-05-21	S�lfonamid-ikame etmi� anelize 5-halka-bile�ikleri.
MD980129A (en)	2000-04-30	Antiherpetic remedy
DE60136706D1 (de)	2009-01-08	Ycin-acryloyl derivate und antimetabolische mitteln
MD2053B1 (en)	2002-12-31	Remedy with interferon inducing action
IL150979A0 (en)	2003-02-12	9-alkylamino-1-nitroacridine derivatives